AmerisourceBergen Stock Forecast, Price & News

AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

Is AmerisourceBergen a buy right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AmerisourceBergen stock.
View analyst ratings for AmerisourceBergen or view top-rated stocks.

How has AmerisourceBergen's stock been impacted by COVID-19 (Coronavirus)?

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ABC stock has increased by 55.8% and is now trading at $132.39.
View which stocks have been most impacted by COVID-19.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for AmerisourceBergen.

How can I listen to AmerisourceBergen's earnings call?

AmerisourceBergen will be holding an earnings conference call on Wednesday, February 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 204-525-0658 with passcode "009158".

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Co. (NYSE:ABC) posted its quarterly earnings data on Thursday, November, 4th. The company reported $2.39 EPS for the quarter, beating the consensus estimate of $2.36 by $0.03. The firm earned $58.90 billion during the quarter, compared to analyst estimates of $57.05 billion. AmerisourceBergen had a trailing twelve-month return on equity of 2,040.08% and a net margin of 0.72%. The firm's quarterly revenue was up 19.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.89 EPS.
View AmerisourceBergen's earnings history.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen declared a quarterly dividend on Friday, November 5th. Investors of record on Monday, November 15th will be given a dividend of $0.46 per share on Monday, November 29th. This represents a $1.84 annualized dividend and a yield of 1.39%. The ex-dividend date of this dividend is Friday, November 12th. This is a positive change from AmerisourceBergen's previous quarterly dividend of $0.44.
View AmerisourceBergen's dividend history.

Is AmerisourceBergen a good dividend stock?

AmerisourceBergen pays an annual dividend of $1.84 per share and currently has a dividend yield of 1.38%. AmerisourceBergen has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of AmerisourceBergen is 24.90%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 16.01% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.
View AmerisourceBergen's dividend history.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen updated its FY 2022 earnings guidance on Thursday, November, 18th. The company provided EPS guidance of $10.500-$10.800 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $10.570. The company issued revenue guidance of -.

What price target have analysts set for ABC?

10 brokers have issued 1 year target prices for AmerisourceBergen's stock. Their forecasts range from $114.00 to $162.00. On average, they expect AmerisourceBergen's stock price to reach $144.75 in the next twelve months. This suggests a possible upside of 9.3% from the stock's current price.
View analysts' price targets for AmerisourceBergen or view top-rated stocks among Wall Street analysts.

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the following people:

• Steven H. Collis, Chairman, President & Chief Executive Officer (LinkedIn Profile)
• Robert P. Mauch, Group President & Executive Vice President (LinkedIn Profile)
• James Francis Cleary, Chief Financial Officer & Executive Vice President
• Kathy Habecker Gaddes, Chief Compliance Officer & Executive VP
• Gina K. Clark, Chief Communications & Administration Officer, EVP (LinkedIn Profile)

What is Steve Collis' approval rating as AmerisourceBergen's CEO?

447 employees have rated AmerisourceBergen CEO Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among AmerisourceBergen's employees.

Who are some of AmerisourceBergen's key competitors?

Some companies that are related to AmerisourceBergen include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Owens & Minor (OMI) and Patterson Companies (PDCO).
View all of ABC's competitors.

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Pfizer (PFE).

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by many different retail and institutional investors. Top institutional investors include Coho Partners Ltd. (0.82%), Scout Investments Inc. (0.10%), HealthInvest Partners AB (0.02%), Royal London Asset Management Ltd. (0.02%), DNB Asset Management AS (0.02%) and ProVise Management Group LLC (0.02%). Company insiders that own AmerisourceBergen stock include Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, Jane E Md Henney, John G Chou, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Robert P Mauch, Silvana Battaglia and Steven H Collis.
View institutional ownership trends for AmerisourceBergen.

Which institutional investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., Coho Partners Ltd., M&G Investment Management Ltd., Pendal Group Ltd, Parallel Advisors LLC, IBM Retirement Fund, Koshinski Asset Management Inc., and Birch Capital Management LLC. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Robert P Mauch, Silvana Battaglia, and Steven H Collis.
View insider buying and selling activity for AmerisourceBergen or view top insider-selling stocks.

Which institutional investors are buying AmerisourceBergen stock?

ABC stock was purchased by a variety of institutional investors in the last quarter, including HealthInvest Partners AB, Wolf Group Capital Advisors, Crossmark Global Holdings Inc., Diversified Trust Co, Community Capital Management LLC, Park National Corp OH, State of Alaska Department of Revenue, and DNB Asset Management AS.
View insider buying and selling activity for AmerisourceBergen or or view top insider-buying stocks.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $132.39.

How much money does AmerisourceBergen make?

AmerisourceBergen has a market capitalization of $27.55 billion and generates $213.99 billion in revenue each year. The company earns $1.54 billion in net income (profit) each year or $7.39 on an earnings per share basis.

How many employees does AmerisourceBergen have?

AmerisourceBergen employs 42,000 workers across the globe.

Does AmerisourceBergen have any subsidiaries?

The following companies are subsidiares of AmerisourceBergen: ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group AG, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Oncology Network Solutions Inc., IntrinsiQ, Lash Group, MWI Veterinary Supply, MWI Veterinary Supply Co., MWI Veterinary Supply Inc., Network for Medical Communications & Research, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, World Courier, World Courier Group S.à r.l., and Xcenda.

When was AmerisourceBergen founded?

AmerisourceBergen was founded in 2001.

What is AmerisourceBergen's official website?

The official website for AmerisourceBergen is www.amerisourcebergen.com.

Where are AmerisourceBergen's headquarters?

AmerisourceBergen is headquartered at 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at (610) 727-7000, via email at [email protected], or via fax at 800-640-5221.